Pancragen — Vendor Pricing & Purity Guide
Research Overview
Pancragen is a synthetic tetrapeptide bioregulator targeting pancreatic tissue. Developed by Dr. Khavinson, it modulates gene expression in pancreatic cells and has been studied for improving insulin secretion and pancreatic function in diabetes and age-related metabolic decline.
In clinical studies, Pancragen improved glucose metabolism parameters and insulin sensitivity in patients with type 2 diabetes when used as adjunctive therapy.
Key Research Findings
- •Improved insulin secretion in pancreatic beta cell models
- •Enhanced glucose metabolism in type 2 diabetes patients as adjunctive therapy
- •Modulated gene expression in pancreatic tissue
- •Promoted pancreatic cell survival under metabolic stress
Research Dosage Protocols
Administered in 10-day courses of 10 mg daily via intramuscular injection, repeated 2-3 times annually.
For research reference only. Not medical advice. Not for human consumption.
Price Comparison (7 products from 7 vendors)
| Vendor | Price | Stock |
|---|---|---|
| Swiss Chems | $59.95 $3.00/mg 20mg vial | In Stock |
| Pure Rawz | $61.78 $3.09/mg 20mg vial | In Stock |
| Core Peptides | $63.00 $3.15/mg 20mg vial | In Stock |
| Soma Chems | $64.99 $3.25/mg 20mg vial | In Stock |
| Peptide Sciences | $65.00 $3.25/mg 20mg lyophilized | In Stock |
| Limitless Biotech | $65.00 $3.25/mg 20mg lyophilized | Out |
| BioLongevity Labs | $94.97 $4.75/mg 20mg vial | In Stock |
Frequently Asked Questions
What is Pancragen?
Pancragen is a tetrapeptide bioregulator targeting the pancreas. It supports insulin secretion and has been studied for type 2 diabetes and age-related metabolic decline.